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Background: Burkholderia pseudomallei is the etiological agent of melioidosis and a CDC category B select agent
with no available effective vaccine. Previous immunizations in mice have utilized the lipopolysaccharide (LPS) as a
potential vaccine target because it is known as one of the most important antigenic epitopes in B. pseudomallei.
Complicating this strategy are the four different B. pseudomallei LPS O-antigen types: A, B, B2, and rough.
Sero-crossreactivity is common among O-antigens of Burkholderia species. Here, we identified the presence of
multiple B. pseudomallei O-antigen types and sero-crossreactivity in its near-neighbor species.
Results: PCR screening of O-antigen biosynthesis genes, phenotypic characterization using SDS-PAGE, and
immunoblot analysis showed that majority of B. mallei and B. thailandensis strains contained the typical O-antigen
type A. In contrast, most of B. ubonensis and B. thailandensis-like strains expressed the atypical O-antigen types B
and B2, respectively. Most B. oklahomensis strains expressed a distinct and non-seroreactive O-antigen type, except
strain E0147 which expressed O-antigen type A. O-antigen type B2 was also detected in B. thailandensis 82172, B.
ubonensis MSMB108, and Burkholderia sp. MSMB175. Interestingly, B. thailandensis-like MSMB43 contained a novel
serotype B positive O-antigen.
Conclusions: This study expands the number of species which express B. pseudomallei O-antigen types. Further
work is required to elucidate the full structures and how closely these are to the B. pseudomallei O-antigens, which
will ultimately determine the efficacy of the near-neighbor B serotypes for vaccine development.Background
Lipopolysaccharide (LPS) is an amphiphilic molecule
which is a major component in the outer membrane of
Gram-negative bacteria [1]. It is composed of three parts
– a membrane bound lipid A, or endotoxin, a core oligo-
saccharide, and a repeating O-antigen [2]. The lipid A is
the signal that triggers the innate immune system during
infection and is structurally conserved across genera with
differences in immune response attributable to the pres-
ence of varying fatty acids [1,3,4]. The O-antigen is the
most structurally diverse LPS component within a spe-
cies, with over 170 known structures in Escherichia coli* Correspondence: Apichai.Tuanyok@nau.edu
1Center for Microbial Genetics and Genomics, Northern Arizona University,
Flagstaff, AZ, USA
Full list of author information is available at the end of the article
© 2012 Stone et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the oralone [1]. As an antigenic determinant, O-antigen struc-
tures can be grouped by serotype [2].
Burkholderia pseudomallei is a saprophytic Gram-
negative bacterium endemic to Southeast Asia and Aus-
tralia. It is the etiological agent of the septicemic
disease melioidosis and a CDC category B select agent
with no available effective vaccine [5,6]. However, lim-
ited success has been met with use of LPS from
B. pseudomallei and the avirulent near-neighbor B.
thailandensis in rodent and rabbit melioidosis models
[7-10]. Four distinct O-antigen ladder patterns have
been described in B. pseudomallei, known as types A,
B, B2, and rough, which lacks the repeating unit [11].
Most B. pseudomallei strains express type A O-antigen,
making it by far the most abundant structure, whereas
the atypical types, B and B2, are serologically related
but have distinct ladder banding patterns when run ontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Stone et al. BMC Microbiology 2012, 12:250 Page 2 of 8
http://www.biomedcentral.com/1471-2180/12/250SDS-PAGE [11]. Type A is also found in B. thailanden-
sis and the virulent B. mallei [12,13]. This is also the
only O-antigen that has been structurally characterized,
containing a disaccharide 3)-β-D-glucopyranose-(1,3)-
6d-α-L-talopyranose-(1 repeat, with the talose residue
variably acetylated and methylated [13-16]. Type B has
not been found in any other species while type B2 was
recently described in a B. thailandensis-like species
[11]. B. thailandensis-like species is a new species
within the Pseudomallei phylogenetic group which is
closely related to B. pseudomallei and B. thailandensis.
This new species was first discovered in soil and water
in northern Australia [17]. The presence of types A and
B2 in near-neighbor species suggests that further
screening will reveal additional species expressing B.
pseudomallei O-antigen types.
In our present study, LPS genotyping and phenotypic
analyses of numerous near-neighbor isolates suggested
the presence of type A in B. mallei, B. thailandensis, and
B. oklahomensis; type B in B. ubonensis; and type B2 in
B. thailandensis, a B. thailandensis-like species, and B.
ubonensis. Representative strains containing B. pseudo-
mallei O-antigen ladder banding patterns were chosen
for further whole genome sequencing and subjected to
comparative genomics.
Results
16S rRNA and recA sequencing
We confirmed bacterial species on all 113 bacterial
strains using 16S rRNA and recA sequencing techniques
compared to reference strains available in GenBank.
Cutoffs of 99% and 94% were established for species
classification for 16S and recA analyses, respectively
(data not shown). We identified 23 B. mallei, 4 B. okla-
homensis, 12 B. thailandensis, 5 B. thailandensis-like
species, 44 B. ubonensis, and 25 unidentified Burkhol-
deria species strains.Table 1 Prevalence of four B. pseudomallei O-antigen types in
Species Total strains tested
Ty
B. mallei 23
B. oklahomensis 4
B. thailandensis 12
B. thailandensis-like 5
B. cepacia 2
B. multivorans 3
B. ubonensis 44
B. vietnamiensis 1
Unidentified Burkholderia spp. 19
†Strain 82172, collected from French foal.
‡Strain MSMB108, collected from Northern Australian environment.
*Strain MSMB175, a soil strain collected from Australia. This strain is currently beingLPS genotyping (PCR)
Eleven out of 12 B. thailandensis strains had the LPS
genotype A. All 23 tested B. mallei strains also had the
LPS genotype A. LPS genotype B was detected in 11 out
of 44 strains of B. ubonensis. We note that these LPS
genotype B strains were all of Australian origin. LPS
genotype B2 was found in B. thailandensis strain 82172,
and B. thailandensis-like species strains MSMB121,
MSMB122, MSMB712, and MSMB714. This is the first
reported incidence of another O-antigen in B. thailan-
densis while B. thailandensis-like MSMB121 was previ-
ously described as expressing this type [11]. No other
species was positive for type A, B, or B2 (Table 1 and
Additional file 1: Table S1).
LPS phenotyping (SDS-PAGE, silver staining and
immunoblotting)
We identified LPS banding patterns in all tested bacterial
strains by comparing them with known LPS banding
patterns A, B, and B2 in reference B. pseudomallei
strains (Additional file 2: Figure S1). Previously, only
type A O-antigen has been described in B. thailandensis
[11,12]. Eleven out of 12 tested strains expressed a type
A banding pattern consistent with the PCR results. We
note that B. thailandensis strain 82172 had the LPS
genotype B2 via PCR, which was confirmed as serotype
B by immunoblotting (Figure 1). B. pseudomallei strains
expressing type B2 have previously been isolated only in
Australia and Papua New Guinea, while this B. thailan-
densis strain was isolated in France [11,18]. Additionally,
type A was recently described in B. oklahomensis E0147
[11], whereas the remaining three B. oklahomensis
strains isolated from Oklahoma [19] displayed an un-
known non-seroreactive ladder pattern (not shown in
Figure 1).
Twenty-one strains of B. mallei expressed type A O-
antigen while the remaining two strains (ATCC10399near-neighbors
Known B. pseudomallei O-antigen
pe A Type B Type B2 Rough Type
21 0 0 2
1 0 0 0
11 0 1† 0
0 0 4 0
0 0 0 0
0 0 0 0
0 11 1‡ 0
0 0 0 0
0 0 1* 0
proposed as a new Burkholderia species.
Figure 1 Serotype A (a) and B (b) western blots. Lane 1 – B. pseudomallei K96243, 2 – B. thailandensis E264, 3 – B. oklahomensis E0147, 4 – B.
pseudomallei 576, 5 – B. ubonensis MSMB57, 6 – B. pseudomallei MSHR840, 7 – B. thailandensis 82172, 8 – B. thailandensis-like MSMB122, 9 – B.
ubonensis MSMB108, 10 – Burkholderia sp. MSMB175, 11 – B. thailandensis-like MSMB43. Lanes 1–3 are representative of type A strains, Lanes 4–5
are representative of type B strains, Lanes 6–10 are representative of type B2 strains, and Lane 11 contains an unknown serotype B O-antigen.
Stone et al. BMC Microbiology 2012, 12:250 Page 3 of 8
http://www.biomedcentral.com/1471-2180/12/250and NCTC120) expressed rough type. ATCC10399 was
previously described as having an intact ladder [13,20],
but the whole genome sequence (WGS) available in
GenBank shows an IS407A insertion in wbiG
(NZ_CH899681), which would predict a rough type.
IS407A is known as one of the most common insertion
sequence (IS) elements in B. pseudomallei and B. mallei
[21]. NCTC120’s rough type phenotype is consistent
with prior works [13,20]. Further immunoblotting with
the B. mallei LPS-specific mAb 3D11 showed all 21 B.
mallei strains with intact ladder profiles bound this anti-
body while the two rough type strains did not. B. pseu-
domallei K96243 and B. oklahomensis E0147 bound
mAb 3D11, as previously described [11]. Similarly, eight
of the B. thailandensis strains bound mAb 3D11 while
E264, MSMB59, MSMB60, and 82172 did not (Add-
itional file 1: Table S1). Similarly, testing the strains con-
taining type A with the IgM mAb Pp-PS-W, the B.
pseudomallei LPS-specific mAb [13], showed that B.
mallei ATCC23344 and B. oklahomensis E0147 were not
seroreactive while B. pseudomallei K96243 was seroreac-
tive. Notably, nine B. thailandensis strains were seror-
eactive to this mAb, while MSMB59 and MSMB60 were
not. This suggested the existence of seroreactivity diver-
sity within B. thailandensis.
PCR suggested that 11 strains of B. ubonensis would be
positive for type B O-antigen. Immunoblotting confirmed
the expression of type B in all of these, one of which,
MSMB57, was selected for genomic analysis. Another
strain, B. ubonensis MSMB108, was negative for all geno-
types by PCR but displays a ladder pattern identical to thetype B2 B. thailandensis-like MSMB122 (Figure 1). We also
noted that other tested B. ubonensis strains produced dis-
tinct LPS ladder patterns to those of B. pseudomallei, which
were not seroreactive (data not shown). Along with B. thai-
landensis, B. ubonensis was the only species that expressed
more than one type of B. pseudomallei O-antigen.
B. thailandensis-like strains expressed two different O-
antigen ladder patterns, both of which were B serotypes.
Strains MSMB121, 122, 712, and 714 expressed ladder type
B2 (Additional file 1: Table S1), whereas strain MSMB43
expressed a novel serologically related O-antigen not found
in B. pseudomallei. This O-antigen, like type B2, bound the
type B patient’s serum but exhibited a banding pattern un-
like either type B or B2 (Figure 1). This is the first descrip-
tion of a seroreactive O-antigen found in a near-neighbor
species which is unknown in B. pseudomallei.
Burkholderia sp. MSMB175 was negative for all B.
pseudomallei O-antigen types by PCR. The immunoblot-
ting analysis revealed a banding pattern that was similar
to type B2 in higher molecular weight bands (Figure 1).
The O-antigen biosynthesis gene cluster for this strain
was subsequently sequenced and found to be type B2
(GenBank: JQ783347), with a nucleotide identity of 88%
compared to B. pseudomallei MSHR840.
Genomic analysis
Genomic comparison has shown that a homolog of wbiE
gene in B. oklahomensis E0147 (BoklE_010100014785)
had one and five single nucleotide polymorphisms
(SNPs) at the forward and reverse primer binding sites,
respectively. This caused negative PCR results when the
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used. In this study, we have adjusted the LPS genotype
A primers to be able to amplify all Burkholderia species
that contains the LPS genotype A. Similarly, in the type
B2 positive Burkholderia sp. MSMB175, two and five
SNPs were found in the forward and reverse primer pair
binding sites, respectively, revealing why this strain was
negative to PCR. In this study, we did not adjust the
PCR primers to amplify the LPS genotype B2 in this
uncharacterized Burkholderia species.
B. thailandensis E264, MSMB59, and MSMB60 were
compared to determine the reason for the differences in
sero-reactivity with the mAb Pp-PS-W. Four SNPs were
found across the entire gene cluster, however all were
synonymous and the amino acid sequences identical
(data not shown). In addition, comparison of oacA, the
4-O acetyltransferase gene, sequences also revealed no
differences. Further work is required to explain why the
Australian isolates fail to cross react with this mAb.
Ten Burkholderia strains were selected for whole gen-
ome sequencing to confirm the LPS genotypes. These
included B. mallei India 86-567-2, KC237, NCTC120; B.
thailandensis MSMB59, MSMB60, 82172; B. thailanden-
sis-like sp. MSMB121, MSMB122; B. ubonensis MSMB57;
and Burkholderia sp. MSMB175. Comparative genomics
has demonstrated that O-antigen biosynthesis genes in all
three sequenced B. mallei strains were very similar to
those found in a reference LPS genotype A B. mallei
ATCC23344, except that strain NCTC120 had an insertion
mutation in its wbiE gene (GenBank: JN581992). We
noted that the mutation defects the production of O-
antigen ladder pattern in this strain (Additional file 1:
Table S1). In addition, genomic analysis has shown that O-
antigen genes in B. thailandensis MSMB59 and MSMB60
were very similar to those found in a reference LPS geno-
type A B. thailandensis E264. Interestingly, B. thailanden-
sis 82172, and B. thailandensis-like sp. strains MSMB121,
MSMB122, and Burkholderia sp. MSMB175 had O-
antigen genes similar to those found in a reference type B2
B. pseudomallei MSHR840, while B. ubonensis MSMB57
had O-antigen genes which were similar to the genes
found in a reference type B B. pseudomallei 576 [11].
One strain of each species expressing O-antigen types
A, B, or B2 were selected for further genomic compari-
sons. The type A strains B. pseudomallei K96243, B.
mallei ATCC23344, B. thailandensis E264, and B. oklaho-
mensis E0147 had an overall nucleotide similarity of 87.2%
to each other, a genic similarity of 87.2%, and an amino
acid similarity of 88.7% (Additional file 3: Figure S2). The
type B strains B. pseudomallei 576 and B. ubonensis
MSMB57 had an overall nucleotide similarity of 95%, a
genic similarity of 95%, and an amino acid similarity of
95%. The type B2 strains B. pseudomallei MSHR840, B.
thailandensis 82172, B. thailandensis-like MSMB122, andBurkholderia sp. MSMB175 had an overall nucleotide
similarity of 90.2%, a genic similarity of 88%, and an amino
acid similarity of 86.5%. The diversity of genes that
are predicted to be involved in the biosynthesis of LPS
types B and B2 is demonstrated in Figure 2. Comparison
of the novel B serotype found in B. thailandensis-like
MSMB43 with types B and B2 revealed a conservation of
the putative epimerase wbiI and rhamnose synthesis
genes rmlCAB (Figure 2) [11,22]. Transport genes, e.g.,
ABC-transporters, encoding two wzt and one wzm
homologs, are conserved across all three serotype B
ladder types. These wzt and wzm homologs are genes
BUC_3406, BUC_3409, BURP840_LPSb09, BURP840_LPS12,
Bpse38_010100014045, Bpse38_010100014055, and genes
BUC_3408, BURP840_LPSb11, Bpse38_010100014050,
respectively (Figure 2). These gene products are likely
responsible for the sero-crossreactivity observed between
these O-antigens (Figure 1). However, a glycosyl transfer-
ase gene, Bpse_38010100014060 in B. thailandensis-like
MSMB43, which is similar to those found in type B ladder
(gene BUC_3410 in B. pseudomallei 576 and gene
BuMSMB57_LPSb07 in B. ubonensis MSMB57) has no
homology to any of those in the type B2. The type A
strains displayed the greatest level of nucleotide diversity,
suggesting an ancient acquisition of the gene cluster and a
possible ancestral state. Conversely, the type B strains
were the most monomorphic, albeit with fewer species
representative of this type. In addition, the average G+C
content of each cluster was 60.8% for type A, 61% for type
B, and 63.5% for type B2. Given an average genomic G+C
content of 68.1% for the Pseudomallei group, the observed
G+C content of the O-antigen gene clusters is evidence
for horizontal acquisition. This would suggest, however,
that type A was unlikely the ancestral type despite being
the most abundant and genetically diverse today.
Serum sensitivity
Previous studies have shown that B. pseudomallei strains
with type B2 or rough type O-antigens display an
increased sensitivity to killing by 30% NHS [11,23]. To
determine if near-neighbors showed the same effect,
eleven diverse Burkholderia strains expressing type A, B,
or B2 O-antigen were assayed for serum sensitivity. All
type A strains, B. thailandensis E264, MSMB59,
MSMB60, and B. oklahomensis E0147 showed a slight re-
sistance to serum killing, except B. thailandensis TXDOH
which was sensitive to serum killing. The type B2 B. thai-
landensis 82172 showed almost no difference in growth,
and all other strains were sensitive to killing by 30% NHS,
most notably B. ubonensis MSMB108 (Figure 3).
Discussion
O-antigen type A has been described as a disaccharide
glucose-talose repeat in B. pseudomallei, B. mallei, and
Figure 3 Serum sensitivity of B. pseudomallei near-neighbors. B. thailandensis E264, MSMB59, MSMB60 and B. oklahomensis E0147 showed a
slight resistance to killing by 30% NHS while all other strains were susceptible to killing, especially B. ubonensis MSMB108. This is in agreement
with prior studies showing serum sensitivity of B. pseudomallei strains expressing type B2 or rough type O-antigens. Note: Bt, B. thailandensis;
Bt-like, B. thailandensis-like species; Bu, B. ubonensis; Bok, B. oklahomensis; and B.sp, Burkholderia sp.
Figure 2 Genomic comparison of O-antigen serotype B biosynthesis genes. Gene clusters, from top to bottom, of B. pseudomallei 576 (type
B), B. ubonensis MSMB57 (type B), B. thailandensis-like MSMB43 (type B variant), Burkholderia sp. MSMB175 (type B2), B. thailandensis-like MSMB122
(type B2), B. thailandensis 82172 (type B2), B. pseudomallei MSHR840 (type B2), and B. pseudomallei 576 were used to illustrate the diversity of the
serotype B O-antigen biosynthesis gene clusters. Red indicates homology of 78-100% and blue indicates an inversion region with equal
homology.
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group modification. B. pseudomallei modifies the talose
residue with a 2-O methyl/4-O acetyl group or with a 2-
O acetyl/4-O hydroxyl group [15,16]. In B. mallei, re-
gardless of whether the 2-O position is methylated or
acetylated, the 4-O position remains in its native hy-
droxyl state [13]. B. thailandensis has been reported to
have the same modification patterns as B. pseudomallei
[12,14,22], but a recent study by Ngugi, et al., [10] sug-
gests that B. thailandensis E264 features a different pat-
tern. Utilizing gas chromatography/mass spectrometry
(GC/MS) to examine methylation patterns, they con-
cluded this strain does not methylate the 2-O position.
Brett, et al., [14] generated mutants of oacA, the 4-O
acetyltransferase gene, which also had the unexpected
result of a lack of methylation at the 2-O position. This
suggests that the methyl group may be lost during GC/
MS or the E264 strain utilized by Ngugi, et al., [10] may
have undergone mutation in oacA, losing its methylase
capabilities.
In our current study, 21 out of 23 B. mallei strains
expressed intact type A O-antigens while the remaining
two (ATCC10399 and NCTC120) were rough. Two pre-
vious studies showed that B. mallei ATCC10399 had a
full ladder pattern by silver staining and immunoblotting
[13,20]. Our genomic analysis has shown that wbiG gene
which is known to be involved in the biosynthesis of the
type A O-antigen, was disrupted in this strain by
IS407A. This supported our finding that ATCC10399
produced rough LPS. B. mallei NCTC120 was also
known as a rough LPS type due to the disruption of its
wbiE, the glycosyltransferase gene, by IS407A [13,20].
DNA sequencing of this strain in our current study
revealed the absence of this insertion element, however,
a 22 base pair artifact remains in the 30 end of this gene
(GenBank: JN581992), suggesting, IS407A remains active
in this strain. We believe that the artifact sequence of
the IS407A is disruptive enough to yield the same
phenotype as the full insertion.
Eleven strains of B. ubonensis, all Australian environ-
mental isolates, were found to express type B. This O-
antigen type is present in approximately 14% of all B.
pseudomallei isolates of which the vast majority are Aus-
tralian [11]. We report here the first discovery of B.
pseudomallei type B O-antigen in a near-neighbor spe-
cies. Previously, B. ubonenesis was known in Australia
from only two strains, only one of which has been
sequenced and contains an unknown O-antigen biosyn-
thesis gene cluster (NZ_ABBE01000374) [24]. Environ-
mental sampling in northern Australia yielded 44 total
B. ubonensis strains, which was the species most com-
monly isolated. Conversely, only two B. thailandensis
strains were isolated, the same number as Levy, et al.,
found [24]. While no study has examined the abundanceof B. ubonensis in Southeast Asia, it is possible that these
two species occupy a similar environmental niche where
B. ubonensis is able to outcompete B. thailandensis in
Australia. In support this, B. ubonensis isolated from
Papua New Guinea exhibited antibiosis against B. pseu-
domallei [25]. These Australian isolates may produce a
similar compound against B. thailandensis.
B. thailandensis-like species, a new member of the
Pseudomallei group, expresses type B2 and a novel lad-
der pattern seropositive for type B, thus far unknown in
any other species or strain. Curiously, B. thailandensis
82172 expresses type B2, as well, marking the first de-
scription of another O-antigen type in this species. This
strain belongs to a distinct phylogenetic cluster along
with four other geographically diverse B. thailandensis
strains, only one of which was isolated in Asia. This
cluster has been suggested as the beginning of a possible
speciation event and the discovery of type B2 LPS lends
further credence to this idea [26].
Burkholderia sp. MSMB175 is another Australian en-
vironmental isolate which clusters with the Pseudomallei
group on the basis of recA and 16S sequence and may
represent a new species (data not shown). The presence
of type B2 O-antigen (Table 1) supports the possibility
that this strain belongs to the Pseudomallei group.
A 1993 study of northeastern Thai children by Kana-
phun, et al., [27] revealed that 80% are seropositive for
antibodies against B. pseudomallei by the age of four.
Accordingly, over 25% of environmental Burkholderia
isolates in Thailand are B. thailandensis [28]. This sug-
gests that some of these children have instead been
exposed to this species and not B. pseudomallei, espe-
cially given the noted inaccuracies and high background
of indirect hemagglutination assays [29]. Little work has
examined the seropositive rates in Australia, but two
studies in Northern Queensland returned rates of 2.5-
5.7% [30,31]. The high clinical relevance of B. pseudo-
mallei expressing type B or B2 O-antigen, along with the
new apparent abundance of these types in Australian
near-neighbors, suggest similar exposures may result in
false positive diagnoses, as is likely the case in Thailand.
These near-neighbor species are avirulent, B. mallei
excepted, and as such are not limited to the biosafety
regulations that B. pseudomallei is as a biosafety level 3
(BSL-3) organism. Few laboratories worldwide are prop-
erly equipped to handle BSL-3 work and so the finding
of B. pseudomallei type LPS in these non-pathogenic
Burkholderia species will allow many additional labora-
tories the opportunity to work towards vaccine develop-
ment for melioidosis.
Conclusions
B. thailandensis type A O-antigen has been used with
some success to vaccinate mice against B. pseudomallei
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two species in backbone and side group modifications
[12,16,22]. Given the high genetic similarity between
types B and B2 in near-neighbors and B. pseudomallei, it
is likely at least one species will be identical in backbone
and side group modifications, as well. In such a case, it
is possible that particular strain or strains will confer
comparable host immunity upon subsequent challenge
with type B or B2 B. pseudomallei in much the same
way B. thailandensis protects against type A B. pseudo-
mallei challenge.
Methods
Bacterial strains, DNA, and LPS preparations
A total of 113 strains of B. pseudomallei near-neighbors
were used in this study. These included 23 B. mallei, 4 B.
oklahomensis, 12 B. thailandensis, 5 B. thailandensis-like
species, 44 B. ubonensis, and other 25 Burkholderia
strains (Tables 1 and Additional file 1: Table S1). Species
identification was made on the basis of recA and 16S
rRNA sequences [17,18]. B. pseudomallei strains K96243,
576, MSHR840, and MSHR1655 were used as references
for the O-antigen types A, B, B2, and rough, respectively
[11]. All strains were grown on Luria-Bertani (LB) agar
(Difco, USA) for DNA and LPS extractions. DNA was
extracted using the Wizard Genomic DNA Purification
Kit (Promega, Madison, WI, USA), according to the man-
ufacturer’s instructions. LPS was extracted using whole-
cell lysis according to a previous method [11,20] and
separated by SDS-PAGE (Invitrogen, USA).
PCR analysis
Strains were genotyped for B. pseudomallei O-antigen
types via multiplex-SYBR-Green real-time PCR in ac-
cordance with as previously reported [11]. As the
previously published sequences did not detect all near-
neighbors expressing type A, this primer pair was rede-
signed. The new type A primer pair spans the intergenic
space of wbiD and wbiE and the primer sequences are:
LPSA_For, 50-ACGGGATCGTACAGTTTCGGATGCT-30;
and LPSA_ Rev, 50-GAAGATCGTCGCTCGGAGAAT
CGT-30.
Silver staining and serology
Silver staining was first used to validate B. pseudomallei
O-antigen type presence in near-neighbor strains,
following the previously determined criteria for identifica-
tion [11,20]. Samples were then screened for sero-
crossreactivity using sera from two Australian melioidosis
patients, one serum sample per immunoblot analysis.
One patient was infected by B. pseudomallei MSHR1328
expressing type A O-antigen, while another patient
was infected by strain MSHR1079 which expressed type
B O-antigen [11]. The same samples were also testedserologically using the commercially available monoclo-
nal antibody (mAb) 3D11 (Fitzgerald Industries Inter-
national Inc., USA), specific to B. mallei LPS [23].
Additionally, LPS samples from all B. thailandensis
strains were also tested using mAb Pp-PS-W [13] which
is specific to B. pseudomallei type A O-polysaccharide
(O-PS).
Serum-sensitivity testing
The susceptibility of the near-neighbor strains to 30%
normal human serum (NHS; Lonza Group LtD., USA)
was tested according to a previous method [11,23].
Briefly, strains were grown at 37°C overnight with
shaking in LB broth and cell concentrations were equili-
brated. A 1:1,000 dilution of culture was created in TSB-
DC (Trypticase soy broth dialysate –treated with
Chelex-100) media [32], and grown for five hours. A 1:6:3
vol. ratio of the culture: TSB-DC media:undiluted NHS
was incubated for two hours at 37°C with no shaking.
Total bacterial plate counting was performed on these
cultures. E. coli HB101 was used as a negative control.
Whole genome sequencing and genomic analysis
Whole genome sequencing was performed using 454 se-
quencing technology (Roche, USA) by the US Army
Edgewood Chemical Biological Center (ECBC), Aberdeen,
MD. O-antigen biosynthesis gene cluster annotations
were made in comparison to the aforementioned refer-
ence B. pseudomallei types using the BLAST program
and Artemis Comparison Tool (ACT) [33]. Annotated O-
antigen gene sequences of B. mallei strains India 86-567-
2, KC237, NCTC120; B. thailandensis strains MSMB59,
MSMB60, 82172; B. thailandensis-like species strains
MSMB121, MSMB12; B. ubonensis strain MSMB57; and
unidentified Burkholderia sp. strain MSMB175, were
assigned GenBank accessions: JN581990, JN581991,
JN581992, JN581997, JN581998, JQ783347, HQ908420,
JF745809, JF745807, and JF745808, respectively.
Additional files
Additional file 1: Table S1. List of Burkholderia strains used in this
study, and their identified genotypes and phenotypes.
Additional file 2: Figure S1. SDS-PAGE and immunoblotting analyses
of 3 reference LPS banding patterns A, B, and B2 in B. pseudomallei
strains K96243 (lane 1), 576 (lane 2), and MSHR840 (lane 3), respectively.
Panel A is the silver stained SDS-PAGE. Panels B and C are the
immunoblots of LPS samples in panel A which were hybridized against
sera from serotype A and B patients, respectively. Lane 4 is the LPS from
B. pseudomallei strain MSHR1655 which is rough type and not
seroreactive. Lane L is a standard protein ladder.
Additional file 3: Figure S2. Comparison of type A O-antigen
biosynthesis clusters. Type A O-antigen is found in four species, from top to
bottom, B. oklahomensis, B. pseudomallei, B. mallei, and B. thailandensis. Red
indicates nucleotide homology of 78-100%. The glycosyltransferase gene
wbiE (BoklE_010100014785) is truncated in B. oklahomensis E0147 but
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http://www.biomedcentral.com/1471-2180/12/250maintains functional. Conversely, insertion of a thymine into the
methyltransferase wbiD relative to B. pseudomallei K96243 removes the
functionality of this enzyme in E0147, removing it from the comparison.
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